MAY | 2011
TODD SHERER , PHD APPOINTED FOUNDATION CEO
Since joining MJFF in 2004 , Dr . Todd Sherer has been instrumental in setting and implementing MJFF ’ s unique scientific strategy to intervene aggressively in closing crucial gaps that slow potential treatments ’ path from the laboratory to Parkinson ’ s patients . “ Todd has an uncommon ability to look at therapeutic progress from both the scientist and the patient perspectives . He has earned the respect of his research peers , who willingly follow him in new and challenging directions , as well as that of people living with the disease , who support our Foundation and look to us as a source of hope ,” says Michael J . Fox .
10